Wasp venom immunotherapy induces activation and homing of CD4 +CD25+ forkhead box protein 3-positive regulatory T cells controlling TH1 responses

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 2, 2011, Pages

  Kerstan, Andreas ^a   Albert, Christa ^a   Klein, Detlef ^a   Bröcker, Eva B ^a   Trautmann, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Immunotherapy; lymph node; regulatory T cell; tolerance; wasp venom

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; WASP VENOM;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL HOMING; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMETRY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INSECT ALLERGY; LYMPHOID CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TH1 CELL;

EID: 79551493669     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.11.025     Document Type: Article

References (40)

1. U. Müller, U. Thurnheer, R. Patrizzi, J. Spiess, and R. Hoigne Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract Allergy 34 1979 369 378
2. U. Müller, A. Helbling, and M. Bischof Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom Allergy 44 1989 412 418
3. R.C. Aalberse, P.H. Dieges, V. Knul-Bretlova, P. Vooren, M. Aalbers, and J. van Leeuwen IgG4 as a blocking antibody Clin Rev Allergy 1 1983 289 302
4. H. Secrist, C.J. Chelen, Y. Wen, J.D. Marshall, and D.T. Umetsu Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals J Exp Med 178 1993 2123 2130
5. V.A. Varney, Q.A. Hamid, M. Gaga, S. Ying, M. Jacobson, and A.J. Frew Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses J Clin Invest 92 1993 644 651
6. M. Jutel, W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Müller Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures J Immunol 154 1995 4187 4194
7. I. Bellinghausen, G. Metz, A.H. Enk, S. Christmann, J. Knop, and J. Saloga Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects Eur J Immunol 27 1997 1131 1139
8. C.A. Akdis, T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser Role of interleukin 10 in specific immunotherapy J Clin Invest 102 1998 98 106
9. M. Jutel, M. Akdis, F. Budak, C. Aebischer-Casaulta, M. Wrzyszcz, and K. Blaser IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 2003 1205 1214
10. M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, and R. Crameri Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 2004 1567 1575
11. E.M. Ling, T. Smith, X.D. Nguyen, C. Pridgeon, M. Dallman, and J. Arbery Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease Lancet 363 2004 608 615
12. F. Bonifazi, M. Jutel, B.M. Bilo, J. Birnbaum, and U. Muller Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice Allergy 60 2005 1459 1470
13. C. Baecher-Allan, J.A. Brown, G.J. Freeman, and D.A. Hafler CD4+CD25high regulatory cells in human peripheral blood J Immunol 167 2001 1245 1253
14. D. Valmori, A. Merlo, N.E. Souleimanian, C.S. Hesdorffer, and M. Ayyoub A peripheral circulating compartment of natural naive CD4 Tregs J Clin Invest 115 2005 1953 1962
15. N. Seddiki, B. Santner-Nanan, S.G. Tangye, S.I. Alexander, M. Solomon, and S. Lee Persistence of naive CD45RA+ regulatory T cells in adult life Blood 107 2006 2830 2838
16. M.A. Gavin, T.R. Torgerson, E. Houston, P. DeRoos, W.Y. Ho, and A. Stray-Pedersen Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development Proc Natl Acad Sci U S A 103 2006 6659 6664
17. N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, and A. Landay Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J Exp Med 203 2006 1693 1700
18. W. Liu, A.L. Putnam, Z. Xu-Yu, G.L. Szot, M.R. Lee, and S. Zhu CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 2006 1701 1711
19. M. Vukmanovic-Stejic, Y. Zhang, J.E. Cook, J.M. Fletcher, A. McQuaid, and J.E. Masters Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo J Clin Invest 116 2006 2423 2433
20. M. Vukmanovic-Stejic, E. Agius, N. Booth, P.J. Dunne, K.E. Lacy, and J.R. Reed The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo J Clin Invest 118 2008 3639 3650
21. J. Gerdes, H. Lemke, H. Baisch, H.H. Wacker, U. Schwab, and H. Stein Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1984 1710 1715
22. B. Fritzsching, N. Oberle, N. Eberhardt, S. Quick, J. Haas, and B. Wildemann In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death J Immunol 175 2005 32 36
23. M.A. Schneider, J.G. Meingassner, M. Lipp, H.D. Moore, and A. Rot CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells J Exp Med 204 2007 735 745
24. J.C. Ochando, A.C. Yopp, Y. Yang, A. Garin, Y. Li, and P. Boros Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells J Immunol 174 2005 6993 7005
25. M.D. Gunn, S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, and L.T. Williams Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization J Exp Med 189 1999 451 460
26. S.K. Bromley, T.R. Mempel, and A.D. Luster Orchestrating the orchestrators: chemokines in control of T cell traffic Nat Immunol 9 2008 970 980
27. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
28. A. Iellem, L. Colantonio, and D. D'Ambrosio Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells Eur J Immunol 33 2003 1488 1496
29. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
30. G. Senti, P. Johansen, and T.M. Kündig Intralymphatic immunotherapy Curr Opin Allergy Clin Immunol 9 2009 537 543
31. F. Meiler, J. Zumkehr, S. Klunker, B. Ruckert, C.A. Akdis, and M. Akdis In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure J Exp Med 205 2008 2887 2898
32. N. Zhang, B. Schroppel, G. Lal, C. Jakubzick, X. Mao, and D. Chen Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response Immunity 30 2009 458 469
33. L. Colantonio, A. Iellem, F. Sinigaglia, and D. D'Ambrosio Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309 Eur J Immunol 32 2002 3506 3514
34. S.M. Nasser, S. Ying, Q. Meng, A.B. Kay, and P.W. Ewan Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy Eur J Immunol 31 2001 3704 3713
35. C. Alexander, S. Ying, B. Kay, and M. Larche Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects Clin Exp Allergy 35 2005 52 58
36. C.A. Akdis, and M. Akdis Mechanisms and treatment of allergic disease in the big picture of regulatory T cells J Allergy Clin Immunol 123 2009 735 746
37. G. Hansen, G. Berry, R.H. DeKruyff, and D.T. Umetsu Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation J Clin Invest 103 1999 175 183
38. A. Godkin, W.F. Ng, K. Gallagher, G. Betts, H.C. Thomas, and R.I. Lechler Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage? J Allergy Clin Immunol 121 2008 1277 1284
39. M. Vukmanovic-Stejic, Y. Zhang, J.E. Cook, J.M. Fletcher, A. McQuaid, and J.E. Masters Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo J Clin Invest 116 2006 2423 2433
40. N. Seddiki, B. Santner-Nanan, S.G. Tangye, S.I. Alexander, M. Solomon, and S. Lee Persistence of naive CD45RA+ regulatory T cells in adult life Blood 107 2006 2830 2838